西欧における実験情報管理システム（LIMS）市場

Research Overview

Pharmaceutical Mergers and Acquisitions Create Need for Open Standards in LIMS Design

The increasing trend towards mergers and acquisitions in the pharmaceuticals industry in Europe has had a direct impact on the laboratory information management systems (LIMS) market as it brings together multiple solutions of different vendors. The acquiring company then faces the difficult task of establishing effective communication between the various systems so that there are minimal technical incompatibilities and product uncertainties. The challenge for LIMS vendors, therefore, is to develop an open, standardised technology platform to ease end users difficulties in understanding the technicalities of the solution design or minimising training costs. The impact of this challenge will decrease as LIMS vendors introduce a higher degree of configurability in the implementation design.

This Frost & Sullivan research service presents a comprehensive analysis of LIMS implementations and their potential applications in pharmaceuticals research and development as well as manufacturing. The analysis includes primary growth factors, challenges as well as restraints along with detailed revenue forecasts and major opportunities within the market.

Deluge of Data Encourages Scientific Data Management through LIMS

Following the completion of the Human Genome Project, there has been a tremendous surge in biological variable data and pharmaceutical companies are under pressure to research as many as 100 compounds a week. Faced with the challenge of organising this huge volume of data and improving quality control, companies are looking for an integrated platform such as LIMS that effectively combines laboratory research with complex discovery and informatics.

"LIMS has been instrumental in reducing companies time-to-market and streamlining the drug manufacturing process by minimising batch-to-batch rejects and false positives to derive faster and more accurate results," remarks the analyst of this research service. "From a purely sample-centric viewpoint in the past, LIMS has progressed to managing data flow across the enterprise in an optimal manner." With technology developments underway to enhance flexibility and configurability in LIMS solutions, companies can aim to achieve product differentiation by integrating them with researchers and analysing genotype and phenotype variables on the same platform.

Opportunities Abound for Vendors with Strong Product Differentiation

There is no dearth of opportunities for vendors in the technology-driven LIMS market, which is characterised by quick innovation cycles. However, intensifying competition and the strict regulatory climate in the pharmaceuticals industry pose a strong challenge. Vendors that are able to bring out product differentiation to meet the changing laboratory experimental requirements are most likely to succeed.

"Given the high entry costs to the pharmaceutical industry and stringent regulatory measures, LIMS vendors can emerge successful if they develop a product differentiating factor that has the ability to integrate with the laboratory environment and harmonise with the business processes," says the analyst. Companies are already taking steps to make their solutions more interactive and customer-friendly. This is likely to enhance sample traceability, instrument interfacing and final report generation in a formatted manner.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) programme that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behaviour and overall company direction. The foundation of Frost & Sullivans GPS includes:

• Assisting companies to reach their full potential in the core business
• Providing growth strategies to help companies expand into related businesses
• Preemptively redefining the core business during market turbulence
• Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
• Recommending growth management strategies through continuous partnership

To maximise the potential for growth within a firms internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programmes that deliver improved market success. Frost & Sullivans strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients growth.

Benefits of this Service

• Focuses on the growth opportunities for LIMS and their potential in the pharmaceuticals industry
• Analyses the competitive structure and discusses strategic recommendations for technical and business challenges confronting the adoption rate for these applications
• Provides valuable end-user feedback that can help companies move up the value chain on their product offerings

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research service:

• Pharmaceutical research and development (R&D)
• Pharmaceutical manufacturing

Technologies

The following technology is covered in this research service:

• Laboratory Information Management Systems (LIMS): These are information management systems powered by IT in a non-hospital environment. LIMS serves as a centralised knowledge repository and thus eliminates paper records. It organises biological data collection and retrieval, thereby helping researchers improve throughput in their experiments and facilitate resource planning in the organisation.

Whats Included

• Key market trends
• Market revenues by segment
• Technology trends
• Competition structure
• End-user structure
• Strategic recommendations

Table Of Contents

1. Executive Summary

• 1. Industry Snapshot
  • 1. Executive Summary

2. Glossary and Exchange Rates

• 1. Glossary of Terms
  • 1. Glossary
• 2. Exchange Rates
  • 1. Exchange Rates

3. Total Western European Laboratory Information Management Systems Market

• 1. Market Overview
  • 1. Market Overview
• 2. Segmentation
  • 1. Market Segmentation
• 3. Market Engineering Measurements
  • 1. Market Engineering Measurements
• 4. Market Drivers
  • 1. Market Drivers
  • a. Regulatory Bodies Fuelling the Adoption of LIMS in the Manufacturing Environments
  • b. Deluge of Data Encourages Scientific Data Management Through LIMS
  • c. Globalisation and Enterprise Resource Planning Stimulate Technical Advancements for LIMS
  • d. Need for Replacement of Legacy Systems
• 5. Industry Challenges
  • 1. Key Industry Challenges
• 6. Revenue Forecasting Analysis
  • 1. Revenue Forecasts
• 7. Competitive Structure
  • 1. Competitive Landscape
• 8. Geographical Trends
  • 1. Geographical Trends
• 9. Technology Trends
  • 1. Technology Trends
• 10. End-user Segmentation
  • 1. End-user Segmentation

4. Laboratory Information Management Systems Application for Pharmaceutical Research and Development Segment

• 1. Market Overview
  • 1. Background
• 2. Market Engineering Measurements
  • 1. Market Engineering Measurements
• 3. Revenue Forecast Analysis
  • 1. Revenue Forecasts

5. Laboratory Information Management Systems Application for Pharmaceutical Manufacturing Segment

• 1. Market Overview
  • 1. Background
• 2. Market Engineering Measurements
  • 1. Market Engineering Measurements
• 3. Revenue Forecast Analysis
  • 1. Revenue Forecasts

6. Frost & Sullivan Awards

• 1. Frost & Sullivan Award for the Laboratory Information Management Systems Markets in Western Europe
  • 1. Award Description
• 2. Frost & Sullivan Product Line Strategy Award
  • 1. Award Description

7. Strategic Recommendations for Western European Laboratory Information Management Systems Markets

• 1. Possible Strategies
  • 1. Strategies

8. Decision Support Database for Laboratory Information Management Systems in the Western European Market

• 1. Pharmaceutical R&D Expenditure
  • 1. Pharmaceutical R&D Expenditure
• 2. Pharmaceutical R&D Expenditure as a Percentage of the Pharmaceutical Market
  • 1. Pharmaceutical Expenditure as a Percentage of the Pharmaceutical Market
• 3. Number of Biotech Companies
  • 1. Number of Biotech Companies
• 4. Private Investment in Biotechnology
  • 1. Private Investment in Biotechnology
• 5. Government R&D Investment
  • 1. Government R&D Investment in Biotechnology

9. Database of Key Industry Participants

• 1. Database of Key Industry Participants
  • 1. Database of Key Industry Participants